Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Nanophase Announces New Patent

Abstract:
NanophaseTechnologies (Nasdaq: NANX), a technology leader in nanomaterials and advanced nanoengineered products, announced that the Company was issued U.S. Patent No. 7,166,663, entitled "Nanostructured Compositions". The patent describes nanostructured polymeric compositions, containing micron-sized and nano-sized particulate materials, which display synergistic improvements in mechanical properties with significantly enhanced optical properties. Processes for manufacturing the nanostructured compositions are also patented.

Nanophase Announces New Patent

ROMEOVILLE, IL | Posted on March 26th, 2007

"Nanophase continues its leadership in nanomaterials and applications
of nanomaterial technologies, including the development of intermediate
products which enable high-value, coating products," stated Dr. Richard
Brotzman, Nanophase's vice-president of R&D. "We regard this patent as
seminal technology in the coating field and it is significant for the
Company and our partnership with ALTANA Chemie AG, one of the world's
leading suppliers of paint and plastic additives for coatings, printing
inks and plastics. Substantially transparent, abrasion and wear-resistant
nanoparticle coatings have numerous potential applications in many
commercial markets. BYK-Chemie and Nanophase continue working to develop
new products based on this patented technology for multiple applications in
a variety of markets."

####

About Nanophase Technologies
Nanophase Technologies Corporation (NANX), http://www.nanophase.com , is
a leader in nanomaterials technologies and provides nanoengineered
solutions for multiple industrial product applications. Using a platform of
patented and proprietary integrated nanomaterial technologies, the Company
creates products with unique performance attributes from two ISO 9001:2000
and ISO 14001 facilities. Nanophase delivers commercial quantity and
quality nanoparticles, coated nanoparticles, and nanoparticle dispersions
in a variety of media. The Company owns or licenses 18 United States and 48
foreign patents and patent applications. Information about Nanophase may be
found in the Company's public filings or on its website.

This press release contains words such as "expects", "shall", "will",
"believes" and similar expressions that are intended to identify
forward-looking statements within the meaning of the Safe Harbor Provisions
of the Private Securities Litigation Reform Act of 1995. Such statements in
this announcement are made based on the Company's current beliefs, known
events and circumstances at the time of publication, and as such, are
subject in the future to unforeseen risks and uncertainties that could
cause the Company's results of operations, performance and achievements to
differ materially from current expectations expressed in, or implied by,
these forward-looking statements. These risk and uncertainties include the
following: a decision by a customer to cancel a purchase order or supply
agreement in light of the Company's dependence on a limited number of key
customers; uncertain demand for, and acceptance of, the Company's
nanocrystalline materials; the Company's manufacturing capacity and product
mix flexibility in light of customer demand; the Company's limited
marketing experience; changes in development and distribution
relationships; the impact of competitive products and technologies; the
Company's dependence on patents and protection of proprietary information;
the resolution of litigation in which the Company may become involved; and
other risks described in the Company's Form 10K filed March 14, 2007 and
other filings with the Securities and Exchange Commission. In addition, the
Company's forward-looking statements could be affected by general industry
and market conditions and growth rates. Except as required by federal
securities laws, the Company undertakes no obligation to update or revise
these forward-looking statements to reflect new events, uncertainties or
other contingencies.

For more information, please click here

Contacts:



Nanophase Technologies Corporation
1319 Marquette Drive
Romeoville, IL 60446
Phone: +1-630-771-6700
Fax: +1-630-771-0825

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Materials/Metamaterials

Hepatitis virus-like particles as potential cancer treatment February 5th, 2016

Organic crystals allow creating flexible electronic devices: The researchers from the Faculty of Physics of the Moscow State University have grown organic crystals that allow creating flexible electronic devices February 5th, 2016

Researchers discover new phase of boron nitride and a new way to create pure c-BN February 5th, 2016

February 4th, 2016

Announcements

Study reveals how herpes virus tricks the immune system February 5th, 2016

Hepatitis virus-like particles as potential cancer treatment February 5th, 2016

Organic crystals allow creating flexible electronic devices: The researchers from the Faculty of Physics of the Moscow State University have grown organic crystals that allow creating flexible electronic devices February 5th, 2016

Researchers discover new phase of boron nitride and a new way to create pure c-BN February 5th, 2016

Patents/IP/Tech Transfer/Licensing

Joint Efforts by Iranian, Malaysian Scientists Produce Antibacterial Coatings for Isolated Areas February 4th, 2016

Silicon-based metamaterials could bring photonic circuits February 1st, 2016

Therapeutic Solutions International Licenses Dexosome Clinical Stage Cancer Immunotherapy Product From Gustave Roussy European Cancer Centre: FDA Cleared Immuno-Oncology Technology to Resume Clinical Development for Solid Tumor Patients January 27th, 2016

Light-activated nanoparticles prove effective against antibiotic-resistant 'superbugs' January 19th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic